Marcin Frąckiewicz

Marcin Frąckiewicz is the founder and CEO of TS2 Space, a satellite communications company serving customers around the world. A graduate of the Warsaw School of Economics (SGH), he has more than two decades of experience in telecommunications, satellite services and technology ventures. He writes about satellite communications, space technology, artificial intelligence and the stock market, with a particular focus on technology companies, semiconductors, emerging industries and the trends shaping global innovation. Follow Marcin Frąckiewicz on Google News, Facebook. or Linkedin.

Orkla India IPO Listing Today: Shares List at 2.75–3% Premium, Slip Up to 7% Intraday; GMP, Subscription & Analyst Views (Nov 6, 2025)

Orkla India IPO Listing Today: Shares List at 2.75–3% Premium, Slip Up to 7% Intraday; GMP, Subscription & Analyst Views (Nov 6, 2025)

MUMBAI | Thursday, November 6, 2025 — Packaged‑foods maker Orkla India made a muted stock‑market debut on Thursday, listing at a modest premium to the IPO price before giving up gains during the session. The stock opened at ₹750.10 on the NSE and ₹751.50 on the BSE vs an issue price of ₹730, but later slipped below the IPO price, underperforming grey‑market expectations that had signaled a stronger start. Business Standard+1
6 November 2025
·
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 06.11.2025

ENDEDLive coverage has endedEnded: November 7, 2025, 12:00 AM EST Confluent Stock 2025 Outlook: Is the Recent Drop Creating an Undervalued Opportunity? November 6, 2025, 11:58 PM EST. Confluent's stock has swung recently, down 20.2% YTD and 16.9% YoY, with a 4.7% drop last week and a 6.0% rise over the past month, as investors weigh real-time data platform demand and competitive dynamics. The stock landscape is buoyed by partnerships and launches in the cloud data infrastructure space, feeding both long-term optimism and short-term volatility. Our analysis marks Confluent as undervalued on traditional checks: a DCF framework yields an intrinsic
6 November 2025
··
Gold Bonanza 2025: Price Soars Past $4,400 as Diamond District Frenzy Hits New York – Is $5,000 Next?

Gold Price Today, Nov 6, 2025: Spot Reclaims $4,000 as Dollar Softens—Traders Eye Fed Path, Shutdown & Tariff Ruling

Top line: Gold moved back above the psychologically important $4,000/oz mark in Thursday trade as the U.S. dollar eased from recent highs and investors weighed a prolonged U.S. government shutdown alongside shifting rate-cut odds and a U.S. Supreme Court case scrutinizing tariffs. As of 09:14 GMT, spot gold was around $4,011.79/oz and December futures near $4,021.20/oz. Silver, platinum and palladium also firmed. Reuters
6 November 2025
Ethereum Price Today, Nov. 6, 2025: ETH steadies near $3.4K as spot ETF outflows stretch to a 6th day; Justin Sun stakes 45K ETH; ‘Fusaka’ upgrade eyed for Dec. 3

Ethereum Price Today, Nov. 6, 2025: ETH steadies near $3.4K as spot ETF outflows stretch to a 6th day; Justin Sun stakes 45K ETH; ‘Fusaka’ upgrade eyed for Dec. 3

After a choppy first half of the week, ether is little changed on the day and holding near the mid‑$3Ks. Intra‑day, ETH traded between roughly $3,277–$3,478 and is hovering around $3.39K at press time. The latest Ethereum market cap reading is about $409B. The bounce follows Tuesday/Wednesday’s broad crypto shakeout that saw more than $1.6B in leveraged positions liquidated across majors, according to CoinDesk’s market desk. CoinDesk+1
6 November 2025
···
Interstellar Comet 3I/ATLAS: A Visitor from Beyond the Solar System

Comet 3I/ATLAS today (6 Nov 2025): China’s Mars orbiter snaps new photos as the interstellar visitor turns bluer and shows puzzling acceleration

China’s space agency says the Tianwen‑1 Mars orbiter used its high‑resolution camera to observe 3I/ATLAS during the object’s close pass by Mars, when the spacecraft was ~30 million km from the comet—one of the nearest probe‑based looks so far. The agency released images and a brief 30‑second sequence showing the comet’s motion, adding that the observation also serves as a technical pathfinder for future small‑body missions. Xinhua News
6 November 2025
Switzerland crosses the crypto Rubicon: TWINT opens to CHF stablecoins & e‑ID as strong franc fuels bond boom — Nov 6, 2025

Switzerland crosses the crypto Rubicon: TWINT opens to CHF stablecoins & e‑ID as strong franc fuels bond boom — Nov 6, 2025

Dateline: Nov 6, 2025 — Switzerland’s carefully managed pivot into digital money and identity gathered pace today, with fresh commentary from the Financial Times amplifying the country’s regulatory push on stablecoins while the payments champion TWINT advances plans to integrate CHF‑backed tokens and the national e‑ID. In parallel, a resurgent Swiss franc is reshaping debt markets, handing bond issuers unusually attractive funding windows in francs. Global Capital+3Financial Times+3TWINT+3
6 November 2025
··
Primerica (NYSE: PRI) Q3 2025 beats: EPS $6.35; revenue $839.9M; record $3.7B ISP sales as investors eye today’s earnings call

Primerica (NYSE: PRI) Q3 2025 beats: EPS $6.35; revenue $839.9M; record $3.7B ISP sales as investors eye today’s earnings call

DULUTH, Ga. — Primerica posted stronger‑than‑expected third‑quarter 2025 results after Wednesday’s close, setting fresh records in its Investment & Savings Products business and topping Wall Street’s earnings and revenue forecasts ahead of its conference call this morning. Total revenue rose 8% year over year to $839.9 million, while GAAP EPS came in at $6.35 and diluted adjusted operating EPS at $6.33, up 11% from a year ago. Management also highlighted record ISP sales of $3.7 billion and quarter‑end client asset values of $126.8 billion. Primerica, Inc.
6 November 2025
··
1 … 229 230 231 232 233 … 409

Stock Market Today

  • Alignment Healthcare (ALHC) Soars 238% in Three Years Despite Ongoing Legal Challenges
    July 25, 2026, 8:05 PM EDT. Alignment Healthcare (ALHC) has jumped 237.9% over three years and returned 65.2% in the last year. The shares remain under pressure from legal issues involving whistleblower claims, yet trade at a price-to-sales ratio of 0.9x, undercutting the Healthcare sector's 1.4x average. Strong value metrics suggest the stock could be undervalued when compared to its sales and industry peers.